TUBERCULOSIS DRUGS MARKET ANALYSIS
Tuberculosis Drugs Market - Regional Insights
On the basis of region, the global tuberculosis drugs market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
Among region, North America is expected to hold a dominant position in the global tuberculosis drugs market over the forecast period, owing to higher cost of TB drugs in the region. For instance, in 2015, the Cycloserine drug for treating multidrug-resistant tuberculosis, increased its price from US$15 per tablet to US$ 360 per tablet owing to transfer of rights to Rodelis Therapeutics.
The market in Europe is expected to grow over the forecast period, owing to high prevalence of tuberculosis in the region. For instance, according to the TB Europe Coalition, in 2015, about 323,000 new TB cases and 32,000 deaths were reported in Europe.
Geographies covered
North America
Latin America
Europe
Asia Pacific
Middle East
Africa
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India :